Intervention

AZD5004

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 9 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials9
Recruiting0
Common conditions4
Lead sponsors shown2
Advertisement

Clinical trials

9 shown
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy ParticipantsNCT07444424 · 2026-03-13
COMPLETED
A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 YearsNCT07455825 · 2026-03-05
COMPLETED
A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes MellitusNCT06988553 · 2025-06-17
COMPLETED
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female ParticipantsNCT06942936 · 2025-05-28
COMPLETED
A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral FormulationsNCT06996886 · 2025-05-22
COMPLETED
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy ParticipantsNCT06948747 · 2025-05-06
COMPLETED
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.NCT06579105 · 2024-10-08
COMPLETED
Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related ComorbidityNCT06579092 · 2024-10-08
COMPLETED
A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy ParticipantsNCT06555822 · 2024-08-15
COMPLETED

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

Trial status mix

COMPLETED9

Phase mix

PHASE17
PHASE22
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.